Craig L. Tendler, MD, discusses the mechanism of action of ibrutinib in various tumor types.
Craig L. Tendler, MD
Advertisement
Articles by Craig L. Tendler, MD
Advertisement
Latest Updated Articles
The Mechanism of Action of IbrutinibPublished: September 10th 2013 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
